These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26510516)

  • 1. Occult Klebsiella pneumoniae bacteremia at emergency department: A single center experience.
    Chang EK; Kao KL; Tsai MS; Yang CJ; Huang YT; Liu CY; Liao CH
    J Microbiol Immunol Infect; 2015 Dec; 48(6):684-91. PubMed ID: 26510516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcome of patients with community-onset Klebsiella pneumoniae bacteremia requiring intensive care.
    Tseng CP; Wu HS; Wu TH; Lin YT; Fung CP
    J Microbiol Immunol Infect; 2013 Jun; 46(3):217-23. PubMed ID: 22832028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality risk score for Klebsiella pneumoniae bacteraemia.
    Chetcuti Zammit S; Azzopardi N; Sant J
    Eur J Intern Med; 2014 Jul; 25(6):571-6. PubMed ID: 24814431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study.
    Liu SW; Chang HJ; Chia JH; Kuo AJ; Wu TL; Lee MH
    J Microbiol Immunol Infect; 2012 Apr; 45(2):113-9. PubMed ID: 22154994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Klebsiella pneumoniae bacteremia revisited: Comparison between 2007 and 2017 prospective cohorts at a medical center in Taiwan.
    Huang YT; Chen CS; Chen HA; Hsu HS; Liang MH; Chang MH; Liao CH
    J Infect; 2020 Nov; 81(5):753-757. PubMed ID: 32860818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can a routine follow-up blood culture be justified in Klebsiella pneumoniae bacteremia? A retrospective case-control study.
    Kang CK; Kim ES; Song KH; Kim HB; Kim TS; Kim NH; Kim CJ; Choe PG; Bang JH; Park WB; Park KU; Park SW; Kim NJ; Kim EC; Oh MD
    BMC Infect Dis; 2013 Aug; 13():365. PubMed ID: 23914899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of bacteremia caused by hypermucoviscous Klebsiella pneumoniae at a tertiary hospital.
    Namikawa H; Yamada K; Sakiyama A; Imoto W; Yamairi K; Shibata W; Yoshii N; Niki M; Nakaie K; Oinuma KI; Tsubouchi T; Niki M; Tochino Y; Takemoto Y; Kaneko Y; Shuto T; Kakeya H
    Diagn Microbiol Infect Dis; 2019 Sep; 95(1):84-88. PubMed ID: 31256940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aspects of the antimicrobial resistence profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients].
    Petrovici CG; Dorobăţ C; Matei M; Teodor A; Luca V; Miftode E
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):769-75. PubMed ID: 22046785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and outcomes for bloodstream infections with extended-spectrum beta -lactamase-producing Klebsiella pneumoniae ; Findings of the nosocomial surveillance system in Hungary.
    Szilágyi E; Füzi M; Böröcz K; Kurcz A; Tóth A; Nagy K
    Acta Microbiol Immunol Hung; 2009 Sep; 56(3):251-62. PubMed ID: 19789140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
    Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
    Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
    Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
    Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacteremia caused by Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases: mortality and readmission-related factors].
    Perianes-Díaz ME; Novo-Veleiro I; Solís-Díaz K; Prolo-Acosta A; García-García I; Alonso-Claudio G
    Med Clin (Barc); 2014 May; 142(9):381-6. PubMed ID: 23735867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and impact of empirical therapy in cirrhotic adults with community-onset bacteremia.
    Hsieh CC; Lee CC; Chan TY; Hong MY; Chi CH; Ko WC
    Am J Emerg Med; 2015 Feb; 33(2):222-8. PubMed ID: 25498529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia.
    Song W; Moland ES; Hanson ND; Lewis JS; Jorgensen JH; Thomson KS
    J Clin Microbiol; 2005 Sep; 43(9):4891-4. PubMed ID: 16145169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mortality risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing microorganisms].
    Ferrández O; Grau S; Saballs P; Luque S; Terradas R; Salas E
    Rev Clin Esp; 2011 Mar; 211(3):119-26. PubMed ID: 21371702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
    Lee CI; Lee NY; Yan JJ; Lee HC; Ko NY; Chang CM; Wu CJ; Chen PL; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of Gram-negative nonfermenters on adults with community-onset bacteremia in the emergency department.
    Chiu CW; Li MC; Ko WC; Li CW; Chen PL; Chang CM; Lee NY; Lee CC
    J Microbiol Immunol Infect; 2015 Feb; 48(1):92-100. PubMed ID: 24060496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
    Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
    Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors, Outcomes, and Mechanisms of Tigecycline-Nonsusceptible Klebsiella pneumoniae Bacteremia.
    Juan CH; Huang YW; Lin YT; Yang TC; Wang FD
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7357-7363. PubMed ID: 27697759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.
    Zarkotou O; Pournaras S; Tselioti P; Dragoumanos V; Pitiriga V; Ranellou K; Prekates A; Themeli-Digalaki K; Tsakris A
    Clin Microbiol Infect; 2011 Dec; 17(12):1798-803. PubMed ID: 21595793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.